FDA is requiring safety labeling changes for opioid pain medicines to further emphasize and characterize the risks associated with long-term use.
FDA is requiring safety labeling changes for opioid pain medicines to further emphasize and characterize the risks associated with long-term use.
No comments yet. Be the first to share your thoughts.